Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
4.500
+0.590 (15.09%)
At close: Feb 27, 2026, 4:00 PM EST
4.470
-0.030 (-0.67%)
After-hours: Feb 27, 2026, 7:13 PM EST
Intelligent Bio Solutions Revenue
Intelligent Bio Solutions had revenue of $896.77K in the quarter ending December 31, 2025, with 47.62% growth. This brings the company's revenue in the last twelve months to $3.58M, up 18.14% year-over-year. In the fiscal year ending June 30, 2025, Intelligent Bio Solutions had annual revenue of $3.05M, down -1.90%.
Revenue (ttm)
$3.58M
Revenue Growth
+18.14%
P/S Ratio
2.02
Revenue / Employee
$65,115
Employees
55
Market Cap
7.22M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Lifeward | 24.50M |
| INVO Fertility | 6.94M |
| Beyond Air | 6.92M |
| Biomerica | 4.46M |
| Tenon Medical | 3.23M |
| Sintx Technologies | 1.27M |
| Movano | 500.00K |
| iTonic Holdings | 305.22K |
INBS News
- 3 days ago - Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry - GlobeNewsWire
- 4 days ago - Intelligent Bio Solutions Partners with Bouygues UK, Part of Multi-Billion Dollar Global Construction Giant Bouygues Construction, for UK Drug Testing Rollout - GlobeNewsWire
- 16 days ago - Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth of 48% with Reader Sales Surging 104% Year-Over-Year - GlobeNewsWire
- 23 days ago - Intelligent Bio Solutions Expects to Report Fiscal Second Quarter 2026 Revenue Growth of Approximately 48% Year-Over-Year, Surpassing $2 Million in Total Revenue for First Half of Fiscal Year - GlobeNewsWire
- 4 weeks ago - Intelligent Bio Solutions Initiates Additional Clinical Studies for FDA 510(k) Submission Supporting Planned Entry into Multi-Billion Dollar U.S. Market - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions Announces Closing of $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions Announces $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 2 months ago - Intelligent Bio Stock Doubles On New Manufacturing Deal Promising Major Cost Cuts - Benzinga